From Our Readers

From Our Readers

You Make the Call

Reader Responses: How long should a young patient with COVID-19 and pulmonary embolism receive...

Here’s how readers responded to a You Make the Call question about anticoagulation for a young patient with COVID-19 and pulmonary embolism. Disclaimer: ASH does...
You Make the Call

Reader Responses: How would you treat a patient with aggressive systemic mastocytosis?

Here’s how readers responded to a You Make the Call question about treatment of bone manifestations and transplantation for systemic mastocytosis. Disclaimer: ASH does not...

Guest Commentary: Rise and Rise Again…

Here, Amrita Krishnan, MD, Nina Shah, MD, and Saad Usmani, MD, reflect on the significance of the swearing in of Kamala Harris, the daughter...
You Make the Call

Reader Responses: How would you treat this patient with poor cytogenetics and low-grade B-cell...

Here’s how readers responded to a You Make the Call question about treatment of low-grade B-cell lymphoma with high-risk cytogenetics. Disclaimer: ASH does not recommend or...

The Future of Chronic Graft-Versus-Host Disease

An Update From the 3rd NIH Chronic GVHD Consensus Conference In this edition, Steven Pavletic, MD, and Kirk Schultz, MD, report on the progress and...
You Make the Call

Reader Responses: Which direct oral anticoagulant would you choose for a submassive pulmonary embolism?

Here’s how readers responded to a You Make the Call question about choice of direct oral anticoagulant (DOAC) for a saddle pulmonary embolism. Disclaimer: ASH...

A Relevant Retirement 

The Department of Medicine at Weill Cornell in New York recently held a 90th birthday celebration for Richard T. Silver, MD, which included Medical...
You Make the Call

Reader Responses: Can I start cytoreductive therapy in a patient with low-risk polycythemia vera?

Here’s how readers responded to a You Make the Call question about cytoreductive therapy in a patient with low-risk polycythemia vera. Disclaimer: ASH does not...
You Make the Call

Reader Responses: How would you treat this patient with JAK2-positive essential thrombocythemia?

Here’s how readers responded to a You Make the Call question about anticoagulation in a patient with essential thrombocythemia. Disclaimer: ASH does not recommend or...
You Make the Call

Reader Responses: Is hypogammaglobulinemia alone an indication for treatment for CLL?

Here’s how readers responded to a You Make the Call question about whether hypogammaglobulinemia alone is an indication for treatment of CLL. Disclaimer: ASH does...
Advertisement

Current Issue

April 2021 Volume 7 Issue 5

This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.

Block title